Price target
64.240.000.00%
The 19 analysts offering 1 year price forecasts for 1CYTK have a max estimate of — and a min estimate of —.
Analyst rating
Based on 22 analysts giving stock ratings to 1CYTK in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1CYTK EPS for the last quarter is −0.95 EUR despite the estimation of −1.21 EUR. In the next quarter EPS is expected to reach −1.35 EUR. Track more of Cytokinetics, Incorporated financials and stay on top of what is up with the company.
In the next quarter Cytokinetics, Incorporated revenue is expected to reach 4.90 M EUR. Check out Cytokinetics, Incorporated revenue and earnings and make informed decisions.
According to analysts, 1CYTK price target is 64.24 EUR with a max estimate of 102.93 EUR and a min estimate of 35.17 EUR. Check if this forecast comes true in a year, meanwhile watch Cytokinetics, Incorporated stock price chart and keep track of the current situation with 1CYTK news and stock market news.
We've gathered opinions of 22 analysts rating 1CYTK stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.